Table 3.
|
gp160 |
gp120 |
p66 |
p55 |
p51 |
gp41 |
p31 |
p24 |
p17 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | IgG | IgA | |
HIV-1 infected subjects | ||||||||||||||||||
1 | 3.0 | – | 3.0 | 1.0 | 3.0 | 1.0 | – | – | 3.0 | 1.0 | 3.0 | – | 3.0 | 2.0 | 3.0 | 3.0 | 3.0 | 3.0 |
2 | 2.0 | 2.0 | 1.0 | – | 2.0 | 2.0 | – | – | 1.0 | 2.0 | 3.0 | 3.0 | 1.0 | – | 3.0 | 3.0 | 3.0 | 3.0 |
3 | 2.0 | – | 1.0 | 1.0 | 2.0 | – | – | – | 2.0 | – | 2.0 | – | 1.0 | 1.0 | 3.0 | – | 1.0 | – |
4 | 2.0 | – | 1.0 | – | 2.0 | – | 1.0 | – | 2.0 | – | 1.0 | – | 1.0 | – | 2.0 | 3.0 | 2.0 | 1.0 |
5 | 2.0 | – | 2.0 | – | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | – | 1.0 | – | 3.0 | 3.0 | 2.0 | 2.0 |
6 | 2.0 | 1.0 | 2.0 | – | 2.0 | 1.0 | – | – | 2.0 | 1.0 | 2.0 | 1.0 | 1.0 | – | 2.0 | 2.0 | 2.0 | – |
7 | 2.0 | – | 1.0 | – | 1.0 | – | 1.0 | – | 1.0 | – | 2.0 | – | 1.0 | – | 3.0 | 2.0 | 1.0 | – |
8 | 3.0 | – | 3.0 | – | 3.0 | – | – | – | 3.0 | – | 3.0 | – | 1.0 | – | 1.0 | – | 1.0 | – |
9 | 3.0 | – | 3.0 | – | 3.0 | – | – | – | 2.0 | – | 3.0 | – | 3.0 | – | 3.0 | 1.0 | 3.0 | – |
10 | 3.0 | – | 3.0 | – | 3.0 | – | – | – | 2.0 | – | 3.0 | – | 3.0 | – | 3.0 | 1.0 | 1.0 | – |
11 | 3.0 | – | 3.0 | 1.0 | 3.0 | – | – | – | 3.0 | – | 2.0 | – | 2.0 | – | 3.0 | – | 3.0 | – |
12 | 3.0 | – | 3.0 | – | 3.0 | – | – | – | 3.0 | – | 3.0 | – | 2.0 | – | 3.0 | – | 2.0 | 3.0 |
13 | 2.0 | – | 1.0 | – | 1.0 | 1.0 | 1.0 | – | 1.0 | – | 2.0 | – | 2.0 | 1.0 | 3.0 | 2.0 | 2.0 | 1.0 |
14 | 3.0 | – | 2.0 | 2.0 | 2.0 | – | – | – | 2.0 | – | 3.0 | – | 2.0 | – | 3.0 | – | 3.0 | – |
15 | 2.0 | 2.0 | 1.0 | – | 1.0 | 2.0 | – | – | 1.0 | 2.0 | 2.0 | 3.0 | 1.0 | 3.0 | 3.0 | 3.0 | 2.0 | 2.0 |
16 | 2.0 | – | 1.0 | – | 3.0 | – | – | 2.0 | – | 2.0 | – | 2.0 | – | 2.0 | 1.0 | 1.0 | – | |
17 | 2.0 | 1.0 | 1.0 | – | 3.0 | 2.0 | 1.0 | 1.0 | 3.0 | 2.0 | 3.0 | 3.0 | 1.0 | 1.0 | 3.0 | 3.0 | 3.0 | 3.0 |
18 | 2.0 | 2.0 | 1.0 | – | 3.0 | – | – | – | 3.0 | – | 2.0 | – | 2.0 | – | 2.0 | 1.0 | 1.0 | 1.0 |
19 | 2.0 | – | 1.0 | – | 3.0 | 1.0 | – | – | 2.0 | – | 3.0 | – | 2.0 | – | 3.0 | 1.0 | 2.0 | – |
20 | 2.0 | – | 1.0 | – | 1.0 | 1.0 | – | – | – | – | – | – | 1.0 | – | 1.0 | 1.0 | – | – |
21 | 2.0 | – | 1.0 | – | 3.0 | 2.0 | 1.0 | – | 2.0 | – | 3.0 | – | 2.0 | 1.0 | 3.0 | 3.0 | 3.0 | 3.0 |
22 | 3.0 | – | 3.0 | – | 3.0 | – | 1.0 | – | 3.0 | – | 3.0 | – | 2.0 | 2.0 | 3.0 | 3.0 | 3.0 | 2.0 |
23 | 3.0 | – | 3.0 | 1.0 | 0.5 | – | – | – | – | – | 3.0 | – | 0.5 | – | 2.0 | 1.0 | – | 1.0 |
24 | 3.0 | – | 2.0 | – | 2.0 | – | 1.0 | – | 2.0 | – | 3.0 | – | 2.0 | – | 3.0 | 3.0 | 3.0 | 3.0 |
25 | 3.0 | – | 3.0 | – | 3.0 | 1.0 | 2.0 | – | 3.0 | 1.0 | 3.0 | 1.0 | 3.0 | – | 3.0 | 1.0 | 3.0 | 1.0 |
26 | 3.0 | 1.0 | 3.0 | – | 3.0 | – | 3.0 | – | 2.0 | – | 3.0 | 1.0 | 3.0 | – | 3.0 | 1.0 | 3.0 | – |
HEPSN subjects | ||||||||||||||||||
1 | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – | |
2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.0 | – | – | – |
4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
10 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
11 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
12 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
13 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
14 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
15 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
16 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
17 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
18 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
19 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
20 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
21 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
22 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
23 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
24 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
25 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.0 | – | – |
26 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
27 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
28 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
29 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
30 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
31 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
32 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
33 | – | – | – | – | – | – | – | – | – | – | – | 2.0 | – | – | – | – | – | – |
34 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.0 | – | – |
35 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
36 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
37 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
38 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – |
39 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
40 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
41 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Assays were performed in Laboratory A as described in the Materials and Methods. Shown is the relative intensity of bands reacting with viral proteins, with greatest intensity indicated by a value of 3.0. Dashes denote the samples that were negative.